THG

THG's Myprotein brand extended multi-year brand licence agreement with Nichols for manufacturing and distribution of new Clear Whey Protein Water RTD product. Builds on successful 2021 collaboration expanding Vimto into functional beverage space.

Leadership read: THG's Myprotein has now committed to physical retail distribution at scale through a third-party manufacturer, which is structurally different from its core direct-to-consumer model. The Nichols arrangement shifts Myprotein's Clear Whey from a digitally-led supplement range into mass-market FMCG, with a £2.99 RSP and nationwide retail placement. That means the brand's performance is now partly governed by shelf-placement economics, retailer margin negotiation, and production yield discipline at Nichols, rather than online conversion and subscription metrics. It also extends the Vimto brand equity arrangement further along the product line, compounding the licensing dependency in both directions. The related signals in the last 90 days are a broad partnership set across sectors with thin direct comparables; none map closely to functional-beverage brand licensing in the UK consumer space. The Unilever-Persil/F1 Academy signal is the nearest thematic cousin, pointing to established FMCG brands extending into adjacent activation frameworks. The honest read here is that this signal stands more on its own than as part of a dense category cluster, though the structural move (D2C nutrition brand reaching consumers via physical retail through a manufacturing partner) mirrors a pattern several UK nutrition brands have attempted in the last two years. Companies at this stage of channel diversification in consumer nutrition consistently surface demand for commercial leadership experienced in retail category management, brand licensing governance, and supply-chain operations where a manufacturing partner holds execution risk. The skill gap that tends to emerge is not in digital or brand but in the physical trade and licensing-compliance functions that D2C-native operators rarely develop internally.

curated · 2026-07-13 · context →

THG reported 6.5% revenue growth in H1 2026 driven by expansion in beauty and nutrition divisions. THG Nutrition (MyProtein) achieved 60% year-to-date unit growth with 18% of direct-to-customer customers now purchasing activewear, signaling category diversification into new product lines.

Leadership read: The operational consequence here is category expansion executed through an existing customer base rather than new acquisition. MyProtein built its direct-to-consumer position on supplement buyers; 18% of that cohort now purchasing activewear means THG has quietly converted a single-category nutrition relationship into a multi-category consumer goods relationship without requiring top-of-funnel spend to do it. That shift commits the business to managing apparel inventory logic, supplier and manufacturing relationships, and returns infrastructure that protein powder fulfilment does not require, a materially different operational problem sitting inside the same P&L. The related signals provided are thin for this specific theme; they span renewable energy, fintech, and AI platforms, with no comparable UK consumer brand category-expansion signals to draw against. Taken on its own, the MyProtein activewear move sits within a broader pattern visible across DTC nutrition and supplement brands. Gymshark's reverse journey from apparel into nutrition adjacencies, and Huel's sustained push into product formats beyond shakes, where the strategic logic is identical: monetise an existing high-trust health consumer rather than acquire a new one. Across companies executing this kind of DTC category extension, the functional pressure concentrates in merchandising and product management capable of running cross-category assortment decisions, and in commercial operations leadership able to hold margin discipline when apparel and consumables share warehouse infrastructure but carry very different return rates and inventory cycles.

curated · 2026-06-24 · context →

THG revealed administrative error in Ingenuity demerger (completed January 2025) involving missing interim accounts filing; company seeking shareholder resolution at June 24 AGM to rectify procedural issues and restore all parties to intended position

Leadership read: The administrative gap here is narrower than it first appears, but its consequences are not. THG completed the Ingenuity demerger in January 2025 without filing interim accounts as at 27 December 2024, a statutory requirement under the Companies Act before distributable reserves can be lawfully transferred. That omission means the distribution was technically deficient at the moment it was made. Filing the accounts retroactively and seeking shareholder ratification via deed of release is the remediation mechanism, but it also means the board has spent the intervening months operating under unresolved legal exposure on a transaction that 88% of shareholders had already approved. The audit committee is now the operational owner of a clean-up exercise that should have been a routine filing step. This is one of 12 restructuring signals we have tracked across the period, though most. Fiinu's reverse-takeover restructuring, Luno's workforce reduction, Rentokil's North America redeployment, reflect strategic pivots rather than procedural compliance failures. The THG situation sits in a smaller and more specific subset: corporate actions where post-transaction governance review, here driven by FRC scrutiny of the Annual Report, has surfaced execution gaps that require retroactive legal remedy. The pattern across companies managing complex demergers or separation transactions is creating durable demand for legal-operations and corporate-governance leadership capable of bridging transaction execution and statutory compliance, functions that tend to be under-resourced precisely when deal teams are at peak capacity.

curated · 2026-05-25 · context →

THG swung back to profit with £54.1m after tax earnings, reversing previous £326m loss, including £103m from sale of Claremont ingredients business

Leadership read: THG's return to profit is structurally different from a trading recovery. The £103m Claremont disposal was the operational pivot, shedding an ingredients manufacturing line that sat awkwardly inside a direct-to-consumer beauty and nutrition platform. What the business has now committed to is a narrower, channel-coherent operating model: fewer asset-heavy divisions, tighter capital allocation, and a P&L that has to justify itself on e-commerce fundamentals rather than on diversified revenue cushions. That is a materially different governance and operating challenge than running a conglomerate structure, and the gap between this year's number and last year's loss is large enough that leadership credibility is now tied to sustaining it without further disposals. This is one of twelve restructuring signals we have tracked across listed businesses in the last 90 days. The comparables are heterogeneous. Standard Chartered divesting its Singapore consumer lending book to refocus on higher-margin segments, ITV Studios preparing for operational independence amid significant revenue pressure, but the consistent shape is the same: portfolio simplification as the precondition for a credible equity story, not the endpoint. Companies that have completed a major divestiture and re-rated on the back of it face a distinct second-phase demand: commercial leadership capable of scaling the retained core without the margin subsidy the sold unit provided, alongside investor-relations and capital-markets capability that can hold the new narrative through execution.

curated · 2026-03-26 · context →